This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Aureo Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Tadaaki Miyazaki: Innovator in Macrophage Phagocytosis
Introduction
Tadaaki Miyazaki is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of immunology, particularly in the activation of macrophages, which play a crucial role in the immune response.
Latest Patents
Miyazaki holds a patent for a "Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages." This innovative composition utilizes an active component derived from natural products to enhance macrophage functions. The patent describes a culture obtained by culturing microorganisms belonging to the genus (sp.) as the active component. This composition is designed to activate macrophage phagocytosis and promote cytokine production, particularly in the context of cancer treatment. It has the potential to activate the phagocytosis of cancer cells or cells that have been damaged by anticancer drugs.
Career Highlights
Miyazaki is associated with Aureo Co., Ltd., where he continues to advance research in his field. His work has garnered attention for its potential applications in cancer therapy and immunology.
Collaborations
Miyazaki collaborates with Yukiko Moriya, contributing to the development of innovative solutions in macrophage activation and cytokine production.
Conclusion
Tadaaki Miyazaki's work in macrophage phagocytosis represents a significant advancement in immunological research. His innovative compositions hold promise for enhancing cancer treatment and improving immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile